Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
European Journal of Clinical Pharmacology|September 3, 2008
Limits of add-on trials: antirheumatic drugsLaura Ottolenghi, Vittorio Bertele', Silvio Garattini
European Journal of Public Health|October 10, 2003
European regulatory policies on medicines and public health needsLuca Li Bassi, Vittorio Bertele, Silvio Garattini
British Journal of Clinical Pharmacology|April 4, 2008
Thrombolysis or nothing for acute myocardial infarction? It's all the same!Vittorio Bertele', Laura Angelici, Simona Barlera, et al.
European Journal of Internal Medicine|September 7, 2015
Approvals of drugs with uncertain benefit-risk profiles in EuropeRita Banzi, Chiara Gerardi, Vittorio Bertele', et al.
European Journal of Internal Medicine|May 30, 2018
A disease looking for innovative drugs: The case of pulmonary arterial hypertensionRoberta Joppi, Chiara Gerardi, Vittorio Bertele', et al.
Cancer Chemotherapy and Pharmacology|November 24, 2016
Clinical research on rare diseases of children: neuroblastomaChiara Gerardi, Rita Banzi, Vittorio Bertele', et al.
Neurology|April 27, 2018
Preapproval and postapproval evidence on drugs for multiple sclerosisChiara Gerardi, Vittorio Bertele', Silvia Rossi, et al.
British Journal of Clinical Pharmacology|October 29, 2019
Food and Drug Administration vs European Medicines Agency: Review times and clinical evidence on novel drugs at the time of approvalRoberta Joppi, Vittorio Bertele, Tommaso Vannini, et al.
European Journal of Clinical Pharmacology|January 4, 2020
Clinical evidence supporting the marketing authorization of biosimilars in EuropeEleonora Allocati, Vittorio Bertele', Chiara Gerardi, et al.
European Journal of Clinical Pharmacology|May 9, 2007
Efficacy and safety of immunosuppressive drugs approved in EU through the centralised procedureVittorio Bertele', Carmela Buonocore, Francesca Michelacci, et al.
Pageof 4